Clinical evaluation of urine laminin-γ2 monomer as a potent biomarker for non-muscle invasive bladder cancer.
Takashi KarashimaSusumu UmemotoTakeshi KishidaKimito OsakaMasatoshi NakagawaEisaku YoshidaToru YoshimuraMasahiko SakaguchiHiroyuki NishimotoMami TaiKeiji InoueMotoharu SeikiNaohiko KoshikawaTaro ShuinPublished in: Cancer medicine (2022)
These results suggest urine Ln-γ2m as a potentially useful biomarker for NMIBC, particularly in cases of low-grade cancer.